Found 482 results in Expert Content

Summary: The chemical stability challenges associated with many small molecule active pharmaceutical ingredients (API) necessitate the need for parenteral options for drug delivery.

Summary: This document provides both a high-level overview of Catalent’s stand-alone small molecule analytical services (on front), and a detailed list of services organized by functional area...

Summary: Pharmaceutical and biotechnology companies approach external development and manufacturing partners for solutions for their product’s specific needs.  New products are increasingly...

Summary: Lipid formulation and spray-dried dispersions are widely used, and proven technologies to overcome bioavailability challenges for poorly soluble molecules.  For selecting the...

Summary: Get an insight into what it takes to move a pre-clinical drug candidate to a Phase 1 clinical trial. The presentations will provide guidance on non-clinical and regulatory considerations...

Summary: The use of spray drying to manufacture amorphous dispersions is continuing to grow due to the number of drug candidates exhibiting poor solubility. In a recent Pharmaceutical...

Summary: Determining a client’s primary goal is critical to guiding them through the development of their asset. Additionally, their primary focus will impact the strategy used to develop...

Summary: Achieving success in early development is essential in progressing to your molecule’s next milestone. While solving solubility is a major hurdle to overcome in early development...

Summary: ​Spray-drying technology is one of the methods of manufacturing high-quality amorphous solid dispersions. The application of a phase-appropriate quality-by-design...

Summary: Catalyst + Talent. Our name combines these ideas. From drug and biologic development to delivery technologies and supply solutions, we are the catalyst for your...